The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study

被引:45
作者
Giordano, G. N. [1 ]
Ohlsson, H. [1 ]
Sundquist, K. [1 ,2 ]
Sundquist, J. [1 ,2 ]
Kendler, K. S. [3 ,4 ,5 ]
机构
[1] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden
[2] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[3] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA
[4] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA
[5] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA
基金
瑞典研究理事会;
关键词
Cannabis; causality; cocaine; co-relative design; schizophrenia; POPULATION-BASED SAMPLE; PSYCHOSIS; RISK; DEPENDENCE; METAANALYSIS; DISORDERS; OUTCOMES; COHORT; ONSET;
D O I
10.1017/S0033291714001524
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. Although cannabis abuse (CA) is known to be associated with schizophrenia, the causal nature of this association is unclear, with prodromal effects complicating its interpretation. Method. From Swedish national registry databases, we used a co-relative case-control design with full-sibling, half-sibling and first-cousin comparisons, alongside a general Swedish population sample. Using ICD codes, 5456 individuals with an initial diagnosis of schizophrenia (2000-2010) were matched with five schizophrenia-free controls. We further identified first-cousin, half-sibling and full-sibling pairs discordant for CA and statistically extrapolated results for discordant monozygotic (MZ) twins. Results. Within the general Swedish population, CA was strongly associated with later schizophrenia [odds ratio (OR) 10.44, 95% confidence interval (CI) 8.99-12.11]. This association was substantially attenuated both by increasing temporal delays between CA exposure and schizophrenia diagnosis and by controlling for increasing degrees of familial confounding. Extrapolated discordant MZ pairs suggested that fully controlling for confounding familial factors reduced the association between CA and later schizophrenia to more modest levels (ORs of approximately 3.3 and 1.6 with 3- and 7-year temporal delays respectively). Opiate, sedative, cocaine/stimulant and hallucinogen abuse were also strongly associated with subsequent schizophrenia in the general population. After controlling for familial confounding, only cocaine/stimulant exposure remained associated. Conclusions. CA has an appreciable causal impact on future risk for schizophrenia. However, population-based estimates of cannabis-schizophrenia co-morbidity substantially overestimate their causal association. Predictions of the cases of schizophrenia that might be prevented by reduced cannabis consumption based on population associations are therefore likely to be considerably overestimated.
引用
收藏
页码:407 / 414
页数:8
相关论文
共 45 条
[1]   CANNABIS AND SCHIZOPHRENIA - A LONGITUDINAL-STUDY OF SWEDISH CONSCRIPTS [J].
ANDREASSON, S ;
ENGSTROM, A ;
ALLEBECK, P ;
RYDBERG, U .
LANCET, 1987, 2 (8574) :1483-1486
[2]   Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study [J].
Arseneault, L ;
Cannon, M ;
Poulton, R ;
Murray, R ;
Caspi, A ;
Moffitt, TE .
BRITISH MEDICAL JOURNAL, 2002, 325 (7374) :1212-1213
[3]   Causal association between cannabis and psychosis: examination of the evidence [J].
Arseneault, L ;
Cannon, M ;
Witton, J ;
Murray, RM .
BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 :110-117
[4]  
Brown TM, 1998, PSYCHIAT SIDE EFFECT
[5]   Methamphetamine Use and Schizophrenia: A Population-Based Cohort Study in California [J].
Callaghan, Russell C. ;
Cunningham, James K. ;
Allebeck, Peter ;
Arenovich, Tamara ;
Sajeev, Gautam ;
Remington, Gary ;
Boileau, Isabelle ;
Kish, Stephen J. .
AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (04) :389-396
[6]   Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis [J].
Chen, CK ;
Lin, SK ;
Sham, PC ;
Ball, D ;
Loh, EW ;
Hsiao, CC ;
Chiang, YL ;
Ree, SC ;
Lee, CH ;
Murray, RM .
PSYCHOLOGICAL MEDICINE, 2003, 33 (08) :1407-1414
[7]   The schizophrenia prodrome revisited: A neurodevelopmental perspective [J].
Cornblatt, BA ;
Lencz, T ;
Smith, CW ;
Correll, CU ;
Auther, AM ;
Nakayama, E .
SCHIZOPHRENIA BULLETIN, 2003, 29 (04) :633-651
[8]   Cannabinoids and psychosis [J].
D'Souza, Deepak Cyril .
INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA, 2007, 78 :289-+
[9]   Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness? [J].
Dalmau, A ;
Bergman, B ;
Brismar, B .
EUROPEAN PSYCHIATRY, 1999, 14 (07) :366-371
[10]   Testing hypotheses about the relationship between cannabis use and psychosis [J].
Degenhardt, L ;
Hall, W ;
Lynskey, M .
DRUG AND ALCOHOL DEPENDENCE, 2003, 71 (01) :37-48